Dr Mike Roberts Joins Health Analytics Provider C2-Ai as Medical Director

C2-AiUK headquartered healthcare analytics company C2-Ai has appointed a senior clinician as its new medical director international.

Dr Mike Roberts, who has a background in emergency medicine and cardiothoracic surgery, has worked in both the NHS and in New Zealand, where he has held chief medical officer and medical director roles for more than 15 years.

He will now work to help expand how C2-Ai’s products are used by healthcare providers - for both new and existing customers. Hospitals within the NHS and internationally use the company's AI-backed technologies to provide them with intelligence to help enhance patient safety and to improve quality and equity of care.

Since the pandemic C2-Ai's systems have also been used to help surgeons safely and efficiently prioritise patients waiting for hospital treatment, with significant results reported by customers around faster clearing of backlogs, fewer emergency admissions and substantial time released for busy surgeons.

Commenting on his appointment, Dr Roberts said: "I have been extremely enthusiastic about the potential of C2-Ai's technology for many years and I have seen the impact it can achieve first hand as a customer, when it comes to supporting clinical governance. Within minutes of using the company's systems, I was able to see evidence needed to help us improve, evidence that would otherwise have taken years to obtain.

"Healthcare organisations are heavily focussed on improving quality and safety, and C2-Ai's products can play an important role for many hospitals in this ambition, providing leaders with objective, quantitative and reliable insight. Anybody who wants to understand the quality of care, can do and at a granular level.

"Put simply, the company's solutions can help healthcare organisations understand where things are not going well so those services can be improved - which is good for patients and saves money. And it shows where things are going well, so that good practice can be exemplified.

"Whether its surgical areas, maternity services, or a whole range of clinical specialities, hospitals and their executive teams have a responsibility to ensure the governance is in place for safety. C2-Ai's systems support that and can help management teams and clinicians have meaningful conversations to improve performance. I'm proud to be part of a highly respected team that is helping with some of the biggest challenges in healthcare."

Steve Mackenney, CEO at C2-Ai, said: "We work with some of the most forward-thinking hospitals in the world when it comes to using data in effective ways to improve healthcare provision for patients. We are thrilled to expand our team with the appointment of Dr Roberts, who has a wealth of experience to help us to expand this offering to even more hospitals, and to help our existing customers make even more of their investments with us."

About C2-Ai

C2-Ai is a trusted NHS digital approved partner with access to full national datasets and running on the HSCN/N3 network. The company has provided national support for the Keogh Review and to Professor Sir Mike Richards at the CQC, and our systems are locally in use in dozens of NHS trusts and in 11 countries.

C2-Ai provides a unique, AI-backed suite of hospital care quality/efficiency improvement tools (CRAB, Patient List Triage, Observatory & Compass). They are developed from 30 years of research, ten years of development and the world's largest (350m) and geographically broadest patient data set (from 46 countries). In the UK these have a track record for delivering demonstrable improvements in:

  • Reducing avoidable harm and unwarranted variation 
  • Reducing length of stay 
  • Reducing critical care demand 
  • Improving clinical cost effectiveness

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...